Please login to the form below

Not currently logged in

UK biotech funding falls 40% between 2018 and 2019


Drop attributed to global uncertainty and Neil Woodford scandal

Lilly will aim for one $1bn-$5bn deal per quarter in 2020

Company seeks to bolster pipeline with a string of M&A activity

Newly-listed BioNTech buys Neon to boost cell therapy assets

BioNTechGerman biotech has agreed to pay $67m in the deal

Biogen just can’t quit Alzheimer’s, licensing another drug from Pfizer

BiogenSnaps up clinical-stage candidate for $75m upfront

Bayer bulks up in women’s health again with non-hormonal contraceptive deal

Bayer symbolIf approved candidate would become a first-in-category therapy

Lilly expands dermatology portfolio with $1.1bn Dermira deal

Deal includes FDA fast-tracked eczema drug

Bayer extends alliance with Evotec in women’s health

Bayer symbolFive-year research agreement focuses on polycystic ovary syndrome

Almirall eyes $62m takeover of multicytokine specialist Bioniz

Almirall logoGains clinical-stage drug for cutaneous T-cell lymphoma

Northsea Therapeutics raises $40m to develop fish oil NASH drug

Northsea therapeuticsLooking for mid-stage trial success in field littered with failures

Business in the USAHealth coverage across state lines

Despite a total lack of legislative wins, the new administration has made its presence felt at home and abroad

  • Ho_Ung_KimStanding out in a crowd

    Celltrion Healthcare’s Ho-Ung Kim on pricing, market access and regulatory challenges for successfully developing biosimilars

  • HeadsThe diseased organisation

    Like humans, organisations can be afflicted by genetic disorders that hinder performance and threaten survival but these can be understood and cured

Featured jobs

Subscribe to our email news alerts


Add my company
Red Health

Red Health was formed in 2007 to bring something fresh to the healthcare PR world. Our approach was simple –...

Latest intelligence

White Paper for download - Explaining the price of your product
In this white paper, he breaks down the pricing options available to you, shares stories from his extensive experiences, and talks you through how to better define your pricing, step-by-step....
OPEN Health expands offering with the launch of a new Learning & Development specialist team
Enhanced expertise to deliver impactful internal training programmes for healthcare clients...
Figure 1 Clarivate
The changing nature of approvals – what does the future hold?
The 2019 CMR International Pharmaceutical R&D Factbook...